Prostate Cancer - Results from #21340

The influence of prior abiraterone treatment on the clinical activity of docetaxel in men with metastatic castration-resistant prostate cancer - Abstract March 3, 2014

Management of enzalutamide, a new hormonal therapy - Abstract March 3, 2014

Pharmacological treatment of patients with advanced prostate cancer - Abstract March 3, 2014

Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy - Abstract March 1, 2014

Targeting metastatic castration-resistant prostate cancer: Mechanisms of progression and novel early therapeutic approaches - Abstract March 1, 2014

Comparison of the morbidity between limited and extended pelvic lymphadenectomy during laparoscopic radical prostatectomy - Abstract March 1, 2014

Stratification of high-risk prostate cancer into prognostic categories: A European multi-institutional study - Abstract March 1, 2014

Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) prognostic tool for prediction of metastases and prostate cancer-specific mortality in patients treated with external beam radiation therapy - Abstract March 1, 2014

Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer - Abstract March 1, 2014

Physician behaviors to promote informed decisions for prostate cancer screening: A national research network study - Abstract March 1, 2014

Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: Our experience in 242 cases - Abstract March 1, 2014

Randomized phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer - Abstract March 1, 2014

Optimization of tomotherapy treatment planning for patients with bilateral hip prostheses - Abstract March 1, 2014

Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer - Abstract February 28, 2014

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study - Abstract February 28, 2014

Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: Comparison of PSA slope and nadir - Abstract February 27, 2014

Molecular imaging of urogenital diseases - Abstract February 27, 2014

Value of MRI in detection of extracapsular extension in prostate cancer: A prospective study comparing imaging and histology - Abstract February 27, 2014

Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy - Abstract February 27, 2014

Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European Compassionate-Use Programme - Abstract February 27, 2014

Page 1068 of 1447